| scholarly article | Q13442814 |
| P50 | author | Caroline Murphy | Q88979449 |
| P2093 | author name string | Richard O'Kennedy | |
| Aoife Crawley | |||
| Bryony Hayes | |||
| P2860 | cites work | Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma | Q81662293 |
| Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer | Q83180901 | ||
| Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells | Q83488143 | ||
| Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS | Q84611412 | ||
| High specificity but low sensitivity of mutation-specific antibodies against EGFR mutations in non-small-cell lung cancer | Q87745890 | ||
| p53 autoantibodies predict subsequent development of cancer | Q23924072 | ||
| Circulating tumor cells: approaches to isolation and characterization | Q24631347 | ||
| An overview of the c-MET signaling pathway | Q24633986 | ||
| Smart nanosystems: Bio-inspired technologies that interact with the host environment | Q26776370 | ||
| Point-of-Care Diagnostics in Low Resource Settings: Present Status and Future Role of Microfluidics | Q26796581 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Emerging biomarkers in the detection and prognosis of prostate cancer | Q28087229 | ||
| Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients | Q28201418 | ||
| Double-stranded DNA in exosomes: a novel biomarker in cancer detection | Q28237711 | ||
| On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database | Q28610113 | ||
| Detection of mutations in EGFR in circulating lung-cancer cells | Q29615033 | ||
| Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET | Q29618139 | ||
| Circulating tumor cells, disease progression, and survival in metastatic breast cancer | Q29619276 | ||
| Identification of Biomarkers for Breast Cancer Using Databases | Q30239810 | ||
| An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancer | Q30358093 | ||
| Glycoprofiling of cancer biomarkers: Label-free electrochemical lectin-based biosensors. | Q30382105 | ||
| Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. | Q31134565 | ||
| Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach | Q33303654 | ||
| A multichannel smartphone optical biosensor for high-throughput point-of-care diagnostics | Q33450702 | ||
| Use of autoantibodies to detect the onset of breast cancer | Q34037876 | ||
| Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer | Q34039531 | ||
| Serum test for assessment of patients with Bence Jones myeloma | Q34176934 | ||
| What are we learning from the cancer genome? | Q34213994 | ||
| Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer | Q34384187 | ||
| Lectins: tools for the molecular understanding of the glycocode. | Q34414486 | ||
| The sweet and sour of cancer: glycans as novel therapeutic targets | Q34439560 | ||
| Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer. | Q34503577 | ||
| Salivary microRNAs as promising biomarkers for detection of esophageal cancer | Q34656109 | ||
| Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN. | Q34661643 | ||
| Diagnostic potential of zinc finger protein-specific autoantibodies and associated linear B-cell epitopes in colorectal cancer | Q35394661 | ||
| Point-of-care rare cell cancer diagnostics | Q35570528 | ||
| Intracellular delivery system for antibody-Peptide drug conjugates | Q35594851 | ||
| The sensitivity, specificity, predictive values, and likelihood ratios of fecal occult blood test for the detection of colorectal cancer in hospital settings | Q36068592 | ||
| Integrated Microfluidic Lectin Barcode Platform for High-Performance Focused Glycomic Profiling | Q36528533 | ||
| Early detection of cancer in the general population: a blinded case-control study of p53 autoantibodies in colorectal cancer. | Q36557829 | ||
| Ultrasensitive clinical enumeration of rare cells ex vivo using a micro-hall detector | Q36701894 | ||
| Circulating tumor cells | Q36729677 | ||
| Glypican-1 identifies cancer exosomes and detects early pancreatic cancer | Q36781050 | ||
| Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review | Q36966177 | ||
| Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer | Q36995204 | ||
| Autoantibodies to tumor-associated antigens: reporters from the immune system | Q37118192 | ||
| An integrated lab-on-a-chip-based electrochemical biosensor for rapid and sensitive detection of cancer biomarkers. | Q51184588 | ||
| Nanostructured optical microchips for cancer biomarker detection. | Q51538898 | ||
| DNA aptamer-based sandwich microfluidic assays for dual quantification and multi-glycan profiling of cancer biomarkers. | Q51580714 | ||
| Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer. | Q52905561 | ||
| A novel saliva-based microRNA biomarker panel to detect head and neck cancers. | Q53025206 | ||
| Rapid and cost-efficient enumeration of rare cancer cells from whole blood by low-loss centrifugo-magnetophoretic purification under stopped-flow conditions. | Q53392858 | ||
| Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. | Q53522277 | ||
| Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer. | Q54335439 | ||
| Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer. | Q54458965 | ||
| Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. | Q55043149 | ||
| Detection of the cyanobacterial toxin, microcystin-LR, using a novel recombinant antibody-based optical-planar waveguide platform | Q56893053 | ||
| Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening | Q57027360 | ||
| A Fall-off in Cervical Screening Coverage of Younger Women in Developed Countries | Q59073437 | ||
| Exosomes: novel biomarkers for clinical diagnosis | Q59121301 | ||
| Single-cell mRNA cytometry via sequence-specific nanoparticle clustering and trapping | Q59714911 | ||
| Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia | Q68179327 | ||
| An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas | Q73182063 | ||
| The detection of serum anti-p53 antibodies from patients with gastric carcinoma in China | Q79756121 | ||
| Mining the plasma proteome for cancer biomarkers | Q37127242 | ||
| Antibody production, design and use for biosensor-based applications | Q37476272 | ||
| Clinically Meaningful Use of Blood Tumor Markers in Oncology. | Q37500722 | ||
| Circulating Biomarkers in Bladder Cancer | Q37530401 | ||
| Point-of-care technologies for molecular diagnostics using a drop of blood | Q37656621 | ||
| Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass. | Q37669086 | ||
| Delivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals | Q37689951 | ||
| Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma. | Q37832580 | ||
| Glycans as cancer biomarkers | Q37969492 | ||
| Biomarkers and transcriptome profiling of lung cancer | Q37988924 | ||
| From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer | Q38023597 | ||
| Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis | Q38060064 | ||
| The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM properties | Q38072603 | ||
| Molecular diagnostics complementing morphology in superficial mesenchymal tumors | Q38074728 | ||
| Advances of lab-on-a-chip in isolation, detection and post-processing of circulating tumour cells | Q38114779 | ||
| Serologic autoantibodies as diagnostic cancer biomarkers--a review | Q38140723 | ||
| Pancreatic cancer stem cells: association with cell surface markers, prognosis, resistance, metastasis and treatment. | Q38219893 | ||
| Fungal lectins: a growing family | Q38239393 | ||
| Recent developments in optical detection technologies in lab-on-a-chip devices for biosensing applications | Q38246674 | ||
| Insights into animal and plant lectins with antimicrobial activities. | Q38311317 | ||
| Role of the interaction between galectin-3 and cell adhesion molecules in cancer metastasis | Q38347625 | ||
| Exosomes and their roles in immune regulation and cancer | Q38365943 | ||
| Exosome mediated communication within the tumor microenvironment | Q38542822 | ||
| The need for effective pancreatic cancer detection and management: a biomarker-based strategy | Q38591066 | ||
| Metabolomic profiling for early cancer detection: current status and future prospects | Q38819884 | ||
| Differential expression of cancer-related proteins in paired breast milk samples from women with breast cancer | Q39565047 | ||
| Characterization and biological implications of membrane lectins in tumor, lymphoid and myeloid cells | Q39609769 | ||
| Carbohydrate-Specific Receptors of the Liver | Q40130920 | ||
| Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. | Q40370221 | ||
| Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. | Q40572162 | ||
| A lectin-based diagnostic system using circulating antibodies to detect cervical intraepithelial neoplasia and cervical cancer | Q41376968 | ||
| Serum glycome profiling: a biomarker for diagnosis of ovarian cancer | Q44204127 | ||
| Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer | Q46663786 | ||
| Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. | Q46821034 | ||
| Plasma low-molecular-weight proteome profiling identified neuropeptide-Y as a prostate cancer biomarker polypeptide | Q47213748 | ||
| Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication | Q47860026 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P577 | publication date | 2018-06-02 | |
| P1433 | published in | Diagnostics | Q27726498 |
| P1476 | title | Developments in Point-of-Care Diagnostic Technology for Cancer Detection | |
| P478 | volume | 8 |
| Q90419464 | 2D Materials in Development of Electrochemical Point-of-Care Cancer Screening Devices |
| Q112750514 | A monolithic single-chip point-of-care platform for metabolomic prostate cancer detection |
| Q92311687 | Current Trends of Nanobiosensors for Point-of-Care Diagnostics |
| Q91982550 | Demonstration of a Low-Cost and Portable Optical Cavity-Based Sensor through Refractive Index Measurements |
| Q98623765 | Glycovariant-based lateral flow immunoassay to detect ovarian cancer-associated serum CA125 |
Search more.